![Frontiers | Trends in Non-invasive Prenatal Screening and Invasive Testing in Denmark (2000–2019) and Israel (2011–2019) | Medicine Frontiers | Trends in Non-invasive Prenatal Screening and Invasive Testing in Denmark (2000–2019) and Israel (2011–2019) | Medicine](https://www.frontiersin.org/files/Articles/768997/fmed-08-768997-HTML/image_m/fmed-08-768997-g001.jpg)
Frontiers | Trends in Non-invasive Prenatal Screening and Invasive Testing in Denmark (2000–2019) and Israel (2011–2019) | Medicine
![Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study | BMC Pregnancy and Childbirth | Full Text Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study | BMC Pregnancy and Childbirth | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12884-020-03298-9/MediaObjects/12884_2020_3298_Fig3_HTML.png)
Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study | BMC Pregnancy and Childbirth | Full Text
![PDF) The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy | Kevin Spencer - Academia.edu PDF) The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy | Kevin Spencer - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42544376/mini_magick20190217-2517-qic4pd.png?1550437471)
PDF) The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy | Kevin Spencer - Academia.edu
First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis | PLOS ONE
![Table 3 from The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy. | Semantic Scholar Table 3 from The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/df64feabd4c7afce8285ca4067ceaa0fef4aeb8e/5-Table3-1.png)
Table 3 from The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy. | Semantic Scholar
![Frontiers | Predictive Performance of Serum β-hCG MoM Levels for Preeclampsia Screening: A Meta-Analysis | Endocrinology Frontiers | Predictive Performance of Serum β-hCG MoM Levels for Preeclampsia Screening: A Meta-Analysis | Endocrinology](https://www.frontiersin.org/files/Articles/619530/fendo-12-619530-HTML-r1/image_m/fendo-12-619530-g001.jpg)
Frontiers | Predictive Performance of Serum β-hCG MoM Levels for Preeclampsia Screening: A Meta-Analysis | Endocrinology
![First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring | Scientific Reports First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-61830-5/MediaObjects/41598_2020_61830_Fig1_HTML.png)